Warnings for asthma drugs.
D000420:Albuterol / Q000009:adverse effects / Q000031:analogs & derivatives; D000730:Androstadienes / Q000009:adverse effects; D001249:Asthma / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000009:adverse effects*; D017277:Drug Approval; D004338:Drug Combinations; D004348:Drug Labeling; D004983:Ethanolamines / Q000009:adverse effects; D000068297:Fluticasone-Salmeterol Drug Combination; D000068759:Formoterol Fumarate; D006801:Humans; D000068299:Salmeterol Xinafoate; D014481:United States; D014486:United States Food and Drug Administration
D000730:Androstadienes; D001993:Bronchodilator Agents; D004338:Drug Combinations; D004983:Ethanolamines; D000068297:Fluticasone-Salmeterol Drug Combination; D000068299:Salmeterol Xinafoate; D000420:Albuterol; D000068759:Formoterol Fumarate